Welcome to YLOAN.COM
yloan.com » Medical » Pharmaceutical industry, second quarter results of listed companies bullish - medicine, performance
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Pharmaceutical industry, second quarter results of listed companies bullish - medicine, performance

Pharmaceutical industry, second quarter results of listed companies bullish - medicine

, performance

At 28, has 116 listed companies to disclose semi-annual report for 2009. According to statistics, although the overall profit fell two percent, but in the second quarter, the performance of most industries and enterprises have realized the chain growth. Industry, Medicine The most robust category growth enterprise performance. Overall profit fell 2 percent The first half of these companies combined business income of 137.7 billion yuan, resulting in operating cost 106.9 billion yuan, compared with same period last year were both down 10%, total net profit of 10.2 billion yuan, down 21%. Internationally Financial Crisis, the listed companies falling profits in the market expected. The data, operating income and operating costs down basic synchronization, and profits fell even more sharply. This shows that prices decline on corporate earnings had a big squeeze space, while the cost of these enterprises have a strong rigid expenditure. Data shows that more than 100 enterprises took place during the first half Sell Total costs and administrative expenses were 6.4 billion and 68 billion yuan, grew by 8% and 4%. Decline in revenue, while cost of sales is still growing, but also highlights the intense competition in the market. From specific distribution of these companies point of view, 116 companies in the performance of 60-year decline, the growth performance of 56 companies, of which three companies to achieve profitability, the amount of three losses have reduced. Although the overall performance declined, but the company's net profit still part of a larger growth in the first half. From the statistical perspective, there are eight performance of the company increased by over 100% year on year, the growth rate of 22 companies in more than 50%. Yitai B shares, the new Salt Lake Potash and adult and 1.71 yuan per share, respectively, 1.05 yuan and 1.027 yuan per share temporarily the top three. Particularly outstanding performance in the pharmaceutical industry Differences between different industries also are obvious. The overall performance of the first half performance was undoubtedly the best medicine, bio-products industry, has been disclosed in the seven semi-annual report of the pharmaceutical companies that have achieved a net profit of five growth, Tong Junge and Xinhua Pharmaceutical increases were as high as 119 % and 95%, * ST biological Although the year a loss, but revenue is still growing, and the loss rate has been significantly reduced over the second half of last year. But only of the income of such company profits double down the Kim group, mainly by the impact of the decline in the real estate business receipts, the biopharmaceutical industry services revenue continues to achieve growth. Thus, in the process of economic contraction, the pharmaceutical company's anti-cyclical feature is very obvious. Compared to the stability of pharmaceutical companies, metal, non-metallic plate is undoubtedly the hardest hit. In the semi-annual report of the 15 disclosure of such enterprises, the five companies for the loss of two-thirds of company performance declined, and the decline was larger, and more than 30%. In addition, Oil Petrochemical, textile, electronics and other industries the company has disclosed in semiannual reports also appeared in performance of more than half. Although the poor performance of some industries in the first half, but some changes are taking place for the better, one quarter of the chain data, Chemical industry , Medicine, real estate, machinery, electronics and information industries company performance increases significantly, iron and steel, nonferrous metal loss of the company's performance increase is also more gratifying.
Comparing Conventional and Alternative Medicines Complement Conventional Medicine with Alternative Methods Keys to a Successful Drug Rehabilitation Avoid Hiring Fake Medical Staff: Understanding the Importance of Primary Source Verification for Medical Screening Certified Medical Coder is in high Demand Acid Reflux Medicine: Helping You Relieve Pain Does Orlistat Work For Losing Weight? Is It A Safe Drug? Clinical Studies Reveal Answers Using a Medical Call Answering Service Medical Answering Service Pitfalls Injection Pen: An Easy, Accurate, And Less Painful Drug Delivery Device! What Are The Drug Free Cures For Acne New Understanding of the Basic Theory of Traditional Chinese Medicine Fighting The Germs Off The Acne Medicine
print
www.yloan.com guest:  register | login | search IP(3.138.37.173) / Processed in 0.009556 second(s), 5 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 2 , 3881, 92,
Pharmaceutical industry, second quarter results of listed companies bullish - medicine, performance